Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Cell Reports|February 5, 2021
Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2Timothy A Bates, Jules B Weinstein, Scotland Farley, et al.
Biorxiv : the Preprint Server for Biology|August 9, 2020
Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2Timothy A Bates, Jules B Weinstein, Scotland E Farley, et al.
JCI Insight|January 26, 2023
An extended interval between vaccination and infection enhances hybrid immunity against SARS-CoV-2 variantsTimothy A Bates, Hans C Leier, Savannah K McBride, et al.
Medrxiv : the Preprint Server for Health Sciences|January 19, 2023
The time between vaccination and infection impacts immunity against SARS-CoV-2 variantsTimothy A Bates, Hans C Leier, Savannah K McBride, et al.
Iscience|February 28, 2022
A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variantsJules B Weinstein, Timothy A Bates, Hans C Leier, et al.
Medrxiv : the Preprint Server for Health Sciences|May 5, 2021
Previously infected vaccinees broadly neutralize SARS-CoV-2 variantsHans C Leier, Timothy A Bates, Zoe L Lyski, et al.
Science Immunology|January 25, 2022
Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variantsTimothy A Bates, Savannah K McBride, Hans C Leier, et al.
Journal of Natural Products|January 10, 2022
Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging VariantsRichard B van Breemen, Ruth N Muchiri, Timothy A Bates, et al.
Pageof 15